Patents by Inventor Craig Thompson

Craig Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220161357
    Abstract: A system and method for automated laser ablation includes an end effector for performing laser ablation at a location with restricted access. The systems and methods of the present disclosure specifically provide for a miniature laser end effector which may be inserted through a port or bore in order to ablate the surface of an internal component of a complex assembly. In several embodiments of the present subject matter, the end effector is mounted on a machine and coupled to a laser system.
    Type: Application
    Filed: February 9, 2022
    Publication date: May 26, 2022
    Inventors: David Scott Diwinsky, Michael Dean Fullington, Herbert Chidsey Roberts, Jacob Cole Hay, Stanley Louis Ream, Craig Thompson Walters
  • Patent number: 11316349
    Abstract: The present disclosure relates to a recloser control that provides autosynchronization of a microgrid to an area electric power system (EPS). For example, a recloser control may include an output connector that is communicatively coupled to a recloser at a point of common coupling (PCC) between the area EPS and the microgrid. The recloser control may include a processor that acquires a first set of measurements indicating electrical characteristics of the area EPS and acquires a second set of measurements indicating electrical characteristics of the microgrid. The recloser control may send synchronization signals to one or more distributed energy resource (DER) controllers to synchronize one or more DERs to the area EPS based on the first set of measurements and the second set of measurements.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: April 26, 2022
    Assignee: Schweitzer Engineering Laboratories, Inc.
    Inventors: Craig Thompson, Scott M Manson
  • Patent number: 11273520
    Abstract: A system and method for automated laser ablation includes an end effector for performing laser ablation at a location with restricted access. The systems and methods of the present disclosure specifically provide for a miniature laser end effector which may be inserted through a port or bore in order to ablate the surface of an internal component of a complex assembly. In several embodiments of the present subject matter, the end effector is mounted on an automated machine and coupled to a laser system.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: March 15, 2022
    Assignee: General Electric Company
    Inventors: David Scott Diwinsky, Michael Dean Fullington, Herbert Chidsey Roberts, Jacob Cole Hay, Stanley Louis Ream, Craig Thompson Walters
  • Patent number: 11262232
    Abstract: Functionality of sensors on a shelf or other inventory location is tested by encouraging an interaction and determining if the output from the sensors on the shelf is consistent with the interaction. An interaction at the shelf can include, for example, a user adding or removing an item from the shelf. To encourage this type of interaction with the shelf or items therein, an announcement may be generated and presented to a user. The announcement may comprise an advertisement with some type of incentive for the user to add or remove an item from the shelf. Upon verifying such an interaction, sensor data before and after the interaction can be compared to generate diagnostic data for the sensor, which can indicate whether the sensor is operational or malfunctioning.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: March 1, 2022
    Assignee: AMAZON TECHNOLOGIES, INC.
    Inventors: Alexander Michael McNamara, Sridhar Boyapati, Aaron Craig Thompson, David Echevarria Ignacio, David William Bettis, Korwin Jon Smith
  • Publication number: 20220054625
    Abstract: The present invention relates to an immunogenic composition comprising two or more polypeptides. The invention also provides nucleic acid molecules and vectors encoding the polypeptides, and methods of using the compositions, nucleic acid molecules and vectors for the prevention or treatment of influenza.
    Type: Application
    Filed: August 27, 2021
    Publication date: February 24, 2022
    Inventors: Craig THOMPSON, Sunetra GUPTA
  • Patent number: 11239659
    Abstract: The present disclosure relates to a recloser control that provides autosynchronization of a microgrid to an area electric power system (EPS). For example, a recloser control may include an output connector that is communicatively coupled to a recloser at a point of common coupling (PCC) between the area EPS and the microgrid. The recloser control may include a processor that acquires a first set of measurements indicating electrical characteristics of the area EPS and acquires a second set of measurements indicating electrical characteristics of the microgrid. The recloser control may send synchronization signals to a microgrid controller to synchronize the microgrid controller based on the first set of measurements and the second set of measurements.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: February 1, 2022
    Assignee: Schweitzer Engineering Laboratories, Inc.
    Inventors: Craig Thompson, Scott M Manson
  • Patent number: 11218023
    Abstract: The present disclosure relates to a recloser control that detects islanding based on a continuous analysis of frequency and rate of change of frequency. For example, a recloser control may include protection circuitry that is communicatively coupled to a recloser. The recloser control may receive measurements of an electrical characteristic in an electric power delivery system. The recloser control may determine frequency (F) and a rate of change of frequency (ROCOF) based on the received measurements. The recloser control may detect islanding of a microgrid in the electric power delivery system based at least in part on F and ROCOF. The recloser control may send a signal to the recloser to trip the recloser based on the islanding of the microgrid.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: January 4, 2022
    Assignee: Schweitzer Engineering Laboratories, Inc.
    Inventors: Scott M Manson, Craig Thompson
  • Patent number: 11123422
    Abstract: The present invention relates to an immunogenic composition comprising two or more polypeptides. The invention also provides nucleic acid molecules and vectors encoding the polypeptides, and methods of using the compositions, nucleic acid molecules and vectors for the prevention or treatment of influenza.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: September 21, 2021
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: Craig Thompson, Sunetra Gupta
  • Publication number: 20200389032
    Abstract: The present disclosure relates to a recloser control that provides autosynchronization of a microgrid to an area electric power system (EPS). For example, a recloser control may include an output connector that is communicatively coupled to a recloser at a point of common coupling (PCC) between the area EPS and the microgrid. The recloser control may include a processor that acquires a first set of measurements indicating electrical characteristics of the area EPS and acquires a second set of measurements indicating electrical characteristics of the microgrid. The recloser control may send synchronization signals to one or more distributed energy resource (DER) controllers to synchronize one or more DERs to the area EPS based on the first set of measurements and the second set of measurements.
    Type: Application
    Filed: June 10, 2019
    Publication date: December 10, 2020
    Applicant: Schweitzer Engineering Laboratories, Inc.
    Inventors: Craig Thompson, Scott M. Manson
  • Publication number: 20200389048
    Abstract: The present disclosure relates to a recloser control that detects islanding based on a continuous analysis of frequency and rate of change of frequency. For example, a recloser control may include protection circuitry that is communicatively coupled to a recloser. The recloser control may receive measurements of an electrical characteristic in an electric power delivery system. The recloser control may determine frequency(F) and a rate of change of frequency (ROCOF) based on the received measurements. The recloser control may detect islanding of a microgrid in the electric power delivery system based at least in part on F and ROCOF. The recloser control may send a signal to the recloser to trip the recloser based on the islanding of the microgrid.
    Type: Application
    Filed: June 10, 2019
    Publication date: December 10, 2020
    Applicant: Schweitzer Engineering Laboratories, Inc.
    Inventors: Scott M. Manson, Craig Thompson
  • Publication number: 20200389027
    Abstract: The present disclosure relates to a recloser control that provides autosynchronization of a microgrid to an area electric power system (EPS). For example, a recloser control may include an output connector that is communicatively coupled to a recloser at a point of common coupling (PCC) between the area EPS and the microgrid. The recloser control may include a processor that acquires a first set of measurements indicating electrical characteristics of the area EPS and acquires a second set of measurements indicating electrical characteristics of the microgrid. The recloser control may send synchronization signals to a microgrid controller to synchronize the microgrid controller based on the first set of measurements and the second set of measurements.
    Type: Application
    Filed: June 10, 2019
    Publication date: December 10, 2020
    Applicant: Schweitzer Engineering Laboratories, Inc.
    Inventors: Craig Thompson, Scott M. Manson
  • Patent number: 10772862
    Abstract: Methods and compositions for treating Ras-related cancers are provided that involve targeting lipid scavenging. Methods and compositions for identifying and/or characterizing more or less responsive cancers are also provided.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: September 15, 2020
    Assignees: The Trustees of Princeton University, Memorial Sloan Kettering Cancer Center
    Inventors: Joshua Rabinowitz, Jurre Kamphorst, Craig Thompson, Justin Cross
  • Publication number: 20200246912
    Abstract: A system and method for automated laser ablation includes an end effector for performing laser ablation at a location with restricted access. The systems and methods of the present disclosure specifically provide for a miniature laser end effector which may be inserted through a port or bore in order to ablate the surface of an internal component of a complex assembly. In several embodiments of the present subject matter, the end effector is mounted on an automated machine and coupled to a laser system.
    Type: Application
    Filed: January 31, 2019
    Publication date: August 6, 2020
    Inventors: David Scott Diwinsky, Michael Dean Fullington, Herbert Chidsey Roberts, Jacob Cole Hay, Stanley Louis Ream, Craig Thompson Walters
  • Patent number: 10733565
    Abstract: Described is an interactive data processing system configured to facilitate selection by a human associate of tentative values generated by an automated system from sensor data. In one implementation, an event may take place in a materials handling facility. The event may comprise a pick or place of an item from an inventory location, movement of a user, and so forth. The sensor data associated with the event is processed by an automated system to determine tentative values associated with the event. In some situations, an uncertainty may exist as to which of the tentative values accurately reflects the actual event. The sensor data and tentative values may be provided to a human associate. The associate may select one of the tentative values. The selected tentative value and the sensor data may be used to train the automated system.
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: August 4, 2020
    Assignee: AMAZON TECHNOLOGIES, INC.
    Inventors: Christopher Andrew Stephens, Alexander Clark Prater, Alexander Michael McNamara, Sridhar Boyapati, David Echevarria Ignacio, David William Bettis, Korwin Jon Smith, Kevin Alexander Lee, Aaron Craig Thompson, Gary Paolo Raden, Sudarshan Narasimha Raghavan, Dilip Kumar, Félix Joseph Étienne Pageau
  • Patent number: 10724895
    Abstract: Described are systems and techniques configured to test sensors in a materials handling facility. In one implementation, an age of a user in the facility and a predicted path through the facility may be determined. Physical access controls may be initiated at inventory locations along the predicted path and adjacent to the user. The physical access controls may include deployment of physical barriers, activation of locks, and so forth. As another user who is permitted access approaches a particular inventory location, the physical access controls may be deactivated.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: July 28, 2020
    Assignee: AMAZON TECHNOLOGIES, INC.
    Inventors: Alexander Michael McNamara, Sridhar Boyapati, Aaron Craig Thompson, David Echevarria Ignacio, David William Bettis, Korwin Jon Smith
  • Patent number: 10711314
    Abstract: Methods of diagnosing subjects having a cell proliferation-related disorder or suspected of having a cell proliferation-related disorder associated with mutant IDH enzymes with 2HG neoactivity.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: July 14, 2020
    Assignee: Agios Pharmaceuticals, Inc.
    Inventors: Leonard Luan C. Dang, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Shin-San Michael Su, Craig Thompson
  • Publication number: 20190276894
    Abstract: Methods of treating and evaluating subjects having neoactive mutants of IDH (e.g., IDH1 or IDH2).
    Type: Application
    Filed: April 26, 2018
    Publication date: September 12, 2019
    Inventors: Leonard Luan C. Dang, Stefan Gross, Hyun Gyung Jang, Shengfang Jin, Shin-San Michael Su, Craig Thompson
  • Publication number: 20190201521
    Abstract: The present invention relates to an immunogenic composition comprising two or more polypeptides. The invention also provides nucleic acid molecules and vectors encoding the polypeptides, and methods of using the compositions, nucleic acid molecules and vectors for the prevention or treatment of influenza.
    Type: Application
    Filed: August 25, 2017
    Publication date: July 4, 2019
    Inventors: Craig THOMPSON, Sunetra GUPTA
  • Publication number: 20190046489
    Abstract: Methods and compositions for treating Ras-related cancers are provided that involve targeting lipid scavenging. Methods and compositions for identifying and/or characterizing more or less responsive cancers are also provided.
    Type: Application
    Filed: October 15, 2018
    Publication date: February 14, 2019
    Inventors: Joshua Rabinowitz, Jurre Kamphorst, Craig Thompson, Justin Cross
  • Patent number: 10130600
    Abstract: Methods and compositions for treating Ras-related cancers are provided that involve targeting lipid scavenging. Methods and compositions for identifying and/or characterizing more or less responsive cancers are also provided.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: November 20, 2018
    Assignees: Memorial Sloan Kettering Cancer Center, The Trustees of Princeton University
    Inventors: Joshua Rabinowitz, Jurre Kamphorst, Craig Thompson, Justin Cross